AXL and pulmonary fibrosis: AXL has recently been reported to drive profibrotic phenotypes in fibroblasts or endothelial cells of renal and pulmonary fibrosis (Möller‐Hackbarth et al, 2021; Yang et al, 2021a, 2021b) and we found that its inhibitor Bemcentinib could obviously restrain the progress of fibrosis and improve functional recovery in the endometrium of IUA.